<?xml version="1.0" encoding="UTF-8"?>
<p>Flu A has been isolated from various species, including humans, contributing to substantial viral heterogeneity, resulting in the production of various subtypes with the potential to cause human pandemic [
 <xref rid="pone.0215514.ref005" ref-type="bibr">5</xref>,
 <xref rid="pone.0215514.ref006" ref-type="bibr">6</xref>]. In contrast, Flu B evolved almost exclusively as a human pathogen, limiting the generation of new strains by reassortment [
 <xref rid="pone.0215514.ref007" ref-type="bibr">7</xref>,
 <xref rid="pone.0215514.ref008" ref-type="bibr">8</xref>]. Two major subtypes of Flu A and two lineages of Flu B viruses co-circulate and cause annual epidemics. In China, since the spread of swine-origin H1N1 in 2009 [
 <xref rid="pone.0215514.ref009" ref-type="bibr">9</xref>], most outbreaks of seasonal flu have been trigged by the transmission of pdmH1N1/2009 (pH1N1) and seasonal A (H3N2) (sH3N2), as well as the type B influenza virus Victoria lineage (B/Victoria) [
 <xref rid="pone.0215514.ref010" ref-type="bibr">10</xref>]. However, low immunization coverage and lack of type B influenza viruses of the Yamagata lineage (B/Yamagata) in the current trivalent influenza vaccine in China would promote its prevalence [
 <xref rid="pone.0215514.ref011" ref-type="bibr">11</xref>].
</p>
